In a deal similar to the one that turned the tide against AIDS, manufacturers and charities will make chemotherapy drugs available in six poor countries at steep discounts

Quick Read

For the first time, doctors have used gene therapy to stave off a fatal degenerative brain disease, an achievement that some experts had thought impossible. The key to making the therapy work? One of medicine’s greatest villains: HIV

Quick Read

With the country in the throes of an epidemic, communities across the nation are being forced to confront the harrowing, and often fatal, effects of opioid abuse. But solutions — such as creating intervention programs in Ohio, providing access to treatment in Alabama, or investing in prevention initiatives in Missouri — cost money

Quick Read

The drug, Mavyret, is the first to be approved by the Food and Drug Administration that can cure all six genetic types of hepatitis C in about two months in patients who haven’t previously been treated. Other approved drugs generally require 12 weeks to treat the disease and often aren’t effective for all types of hepatitis C

Quick Read

Hurricane Maria left a ruined island and 16 Puerto Rico residents dead. But public health experts worry that figure could climb higher in the coming weeks, as many on the island fail to get medicines or treatment they need for chronic diseases

Quick Read

Dinnertime is nearing, and the kitchen in this tidy home is buzzing. Lamyaa Manty, a 29-year-old Iraqi refugee, wears a neon-pink T-shirt and stirs a big pot of eggplant, onion, potatoes and tomatoes on the stove, a staple of Iraqi cooking called tepsi

Quick Read

Julio Alicea’s 8-month-old granddaughter Aubrey came down with severe respiratory problems a day after Hurricane Maria pummeled Puerto Rico. “We are very lucky” Alicea says, “the hospital is open and we live nearby.” Aubrey’s cough turned intense and when she started vomiting, Alicea says he rushed her to the hospital at 4 am

Quick Read

It has been four years since the federal government lifted the age limit for the morning-after pill, but college students across the country say gaining access to it remains fraught with confusion and difficulty

Quick Read